Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,212 | Dovepress* | 17,590+ | 1,085 | 18,675 | |
PubMed Central* | 622 | 208 | 830 | ||
Totals | 18,212 | 1,293 | 19,505 | ||
*Since 13 November 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
12 | 0 | 0 | 0 | 3 | 9 |
View citations on PubMed Central and Google Scholar